Toll Free Survivor Line


OUR MISSION:  To improve the lives of anyone affected by cancers of the liver through  information, resources, and support; deLIVERing HOPE and ensuring

no one makes the cancer journey alone.

Immuno-Oncology A New Option for Liver Cancer

Bristol-Myers Squibb’s Opdivo® (nivolumab)

Receives FDA Approval for the Treatment of Hepatocellular Carcinoma Patients Previously Treated with Sorafenib

  • Opdivo is the first and only Immuno-Oncology agent to receive this FDA approval; this accelerated approval is based on tumor response rate and durability of response in these patients
  • The CheckMate -040 pivotal study evaluated Opdivo in patients with and without active Hepatitis B or C infection, and across PD-L1 expression levels 1,2
  • HCC is the most common type of liver cancer and incidence rates are increasing


Continue Reading

The Bumblebee Buzz


The bumblebee, as our mascot, is used to symbolize all that is possible when you are faced with a diagnosis of liver tumors. "According to the greatest minds of science, a bumblebee cannot fly. Its wings aren't big enough and aerodynamics say it is impossible. But that doesn't deter the bumblebee as it flies anyway." Just like the bumblebee, we are proving that the improbable is possible. Wearing a "bee band" or "YES" pin shows your support in funding the education and research needed to increase the awareness of resources and treatment options available for those affected by liver tumors

Retreat from Cancer

2017 Recap

Join YES and get

your survivor bag

Made possible by Amgen, Genentech and Sirtex


Toll Free Survivor Line



Survivor Hotline: 1-877-937-7478 (US only);

The information presented in this Website is not intended as a substitute for medical care. Please talk with your healthcare provider about any information you get from this Website.

Thank you to Amgen, Genentech, Lilly, Sirtex, and Wako

 for your support in 2017